MiniMed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Net Income	-317	-198	-107	-92
Depreciation & Amortization	156	143	129	115
Stock-Based Compensation	46	41	38	35
Other Adjustments	84	32	54	28
Change in Receivables	-83	-66	-105	-70
Changes in Inventories	-29	-19	5	-28
Changes in Accounts Payable	41	191	-4	14
Changes in Other Operating Activities	-95	16	30	-6
Operating Cash Flow	-197	140	41	-6
Operating Cash Flow Growth	-	241.46%	-	-
Capital Expenditures	-223	-193	-148	-167
Purchases of Investments	-	-	-5	-13
Proceeds from Sale of Investments	-	-	11	-
Other Investing Activities	-10	-	-14	-
Investing Cash Flow	-233	-193	-157	-180
Issuance of Common Stock	538	-	-	-
Net Common Stock Issued (Repurchased)	538	-	-	-
Other Financing Activities	178	10	112	185
Financing Cash Flow	716	10	112	185
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1	-	-	-
Net Cash Flow	287	-43	-4	-1
Free Cash Flow	-420	-53	-107	-173
FCF Margin	-13.54%	-1.95%	-4.33%	-7.71%
Free Cash Flow Per Share	-1.64	-0.21	-0.42	-
Levered Free Cash Flow	-483	-75	-100	-168
Unlevered Free Cash Flow	-468.68	-59.65	-94.46	-155.53

SEC Filings: 10-K · 10-Q